(Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that the company will host a ...
A formal request for a public local inquiry (PLI) on the controversial £54 million Musselburgh Flood Protection Scheme has been made by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback